- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Skin Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Abbott Laboratories
DAMAE Medical
F Hoffmann-La Roche Ltd
DermTech
NeraCare GmbH
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Bristol-Myers Squibb Company
Daiichi Sankyo Company, Limited
Merck & Co, Inc
Qiagen NV
Novartis AG
GlaxoSmithKline PLC
Castle Biosciences, Inc
AB Science
By Type:
Non-melanoma
Melanoma
By Application:
Clinic
Others
Hospital
Laboratory
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Skin Cancer Diagnostics Market Overview 2018-2029
-
1.1 China Skin Cancer Diagnostics Industry Development Overview
-
1.2 China Skin Cancer Diagnostics Industry Development History
-
1.3 China Skin Cancer Diagnostics Industry Market Size (2018-2029)
-
1.4 China Skin Cancer Diagnostics Market Analysis by Type from Production Side
-
1.4.1 China Skin Cancer Diagnostics Production Volume, Production Value and Growth Rate of Non-melanoma (2018-2029)
-
1.4.2 China Skin Cancer Diagnostics Production Volume, Production Value and Growth Rate of Melanoma (2018-2029)
-
1.5 China Skin Cancer Diagnostics Market Analysis by Application from Consumption End
-
1.5.1 China Skin Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China Skin Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Skin Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.4 China Skin Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Laboratory (2018-2029)
-
1.6 China Skin Cancer Diagnostics Market Analysis by Region
-
1.6.1 North China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
Chapter 2 China Skin Cancer Diagnostics Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Skin Cancer Diagnostics Market Status and Competition at home and abroad in 2023
-
2.2.2 China Skin Cancer Diagnostics Market Status and Competition Analysis in 2023
-
2.2.3 China Skin Cancer Diagnostics Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Skin Cancer Diagnostics Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Skin Cancer Diagnostics Industry Development
Chapter 3 Skin Cancer DiagnosticsIndustry Chain Analysis
-
3.1 Skin Cancer Diagnostics Industry Chain
-
3.2 Skin Cancer Diagnostics Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Skin Cancer Diagnostics Market
-
3.3 Skin Cancer Diagnostics Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Skin Cancer Diagnostics Market
Chapter 4 China Skin Cancer Diagnostics Market, by Type
-
4.1 China Skin Cancer Diagnostics Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Skin Cancer Diagnostics Total Production Volume and Growth Rate from Production Side
-
4.5 China Skin Cancer Diagnostics Production Volume and Growth Rate, by Type
-
4.5.1 China Skin Cancer Diagnostics Production Volume and Growth Rate of Non-melanoma
-
4.5.2 China Skin Cancer Diagnostics Production Volume and Growth Rate of Melanoma
Chapter 5 China Skin Cancer Diagnostics Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Skin Cancer Diagnostics Total Market Size and Growth Rate from Consumption End
-
5.5 China Skin Cancer Diagnostics Market Size and Growth Rate, by Application
-
5.5.1 China Skin Cancer Diagnostics Market Size and Growth Rate of Clinic
-
5.5.2 China Skin Cancer Diagnostics Market Size and Growth Rate of Others
-
5.5.3 China Skin Cancer Diagnostics Market Size and Growth Rate of Hospital
-
5.5.4 China Skin Cancer Diagnostics Market Size and Growth Rate of Laboratory
Chapter 6 China Skin Cancer Diagnostics Market, by Region
-
6.1 China Skin Cancer Diagnostics Production Volume and Production Value, by Region
-
6.2 China Skin Cancer Diagnostics Sales Volume and Sales Value, by Region
Chapter 7 North China Skin Cancer Diagnostics Market Analysis
-
7.1 North China Skin Cancer Diagnostics Market, by Type
-
7.2 North China Skin Cancer Diagnostics Market, by Application
Chapter 8 Central China Skin Cancer Diagnostics Market Analysis
-
8.1 Central China Skin Cancer Diagnostics Market, by Type
-
8.2 Central China Skin Cancer Diagnostics Market, by Application
Chapter 9 South China Skin Cancer Diagnostics Market Analysis
-
9.1 South China Skin Cancer Diagnostics Market, by Type
-
9.2 South China Skin Cancer Diagnostics Market, by Application
Chapter 10 East China Skin Cancer Diagnostics Market Analysis
-
10.1 East China Skin Cancer Diagnostics Market, by Type
-
10.2 East China Skin Cancer Diagnostics Market, by Application
Chapter 11 Northeast China Skin Cancer Diagnostics Market Analysis
-
11.1 Northeast China Skin Cancer Diagnostics Market, by Type
-
11.2 Northeast China Skin Cancer Diagnostics Market, by Application
Chapter 12 Southwest China Skin Cancer Diagnostics Market Analysis
-
12.1 Southwest China Skin Cancer Diagnostics Market, by Type
-
12.2 Southwest China Skin Cancer Diagnostics Market, by Application
Chapter 13 Northwest China Skin Cancer Diagnostics Market Analysis
-
13.1 Northwest China Skin Cancer Diagnostics Market, by Type
-
13.2 Northwest China Skin Cancer Diagnostics Market, by Application
Chapter 14 Company Profiles
-
14.1 Abbott Laboratories
-
14.1.1 Abbott Laboratories Company Profile
-
14.1.2 Abbott Laboratories Skin Cancer Diagnostics Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 DAMAE Medical
-
14.2.1 DAMAE Medical Company Profile
-
14.2.2 DAMAE Medical Skin Cancer Diagnostics Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 F Hoffmann-La Roche Ltd
-
14.3.1 F Hoffmann-La Roche Ltd Company Profile
-
14.3.2 F Hoffmann-La Roche Ltd Skin Cancer Diagnostics Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 DermTech
-
14.4.1 DermTech Company Profile
-
14.4.2 DermTech Skin Cancer Diagnostics Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 NeraCare GmbH
-
14.5.1 NeraCare GmbH Company Profile
-
14.5.2 NeraCare GmbH Skin Cancer Diagnostics Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Pfizer Inc
-
14.6.1 Pfizer Inc Company Profile
-
14.6.2 Pfizer Inc Skin Cancer Diagnostics Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Sun Pharmaceutical Industries Ltd
-
14.7.1 Sun Pharmaceutical Industries Ltd Company Profile
-
14.7.2 Sun Pharmaceutical Industries Ltd Skin Cancer Diagnostics Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Bristol-Myers Squibb Company
-
14.8.1 Bristol-Myers Squibb Company Company Profile
-
14.8.2 Bristol-Myers Squibb Company Skin Cancer Diagnostics Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Daiichi Sankyo Company, Limited
-
14.9.1 Daiichi Sankyo Company, Limited Company Profile
-
14.9.2 Daiichi Sankyo Company, Limited Skin Cancer Diagnostics Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Merck & Co, Inc
-
14.10.1 Merck & Co, Inc Company Profile
-
14.10.2 Merck & Co, Inc Skin Cancer Diagnostics Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Qiagen NV
-
14.11.1 Qiagen NV Company Profile
-
14.11.2 Qiagen NV Skin Cancer Diagnostics Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Novartis AG
-
14.12.1 Novartis AG Company Profile
-
14.12.2 Novartis AG Skin Cancer Diagnostics Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 GlaxoSmithKline PLC
-
14.13.1 GlaxoSmithKline PLC Company Profile
-
14.13.2 GlaxoSmithKline PLC Skin Cancer Diagnostics Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Castle Biosciences, Inc
-
14.14.1 Castle Biosciences, Inc Company Profile
-
14.14.2 Castle Biosciences, Inc Skin Cancer Diagnostics Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 AB Science
-
14.15.1 AB Science Company Profile
-
14.15.2 AB Science Skin Cancer Diagnostics Market Performance
-
14.15.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Skin Cancer Diagnostics Industry Research Conclusions
-
15.2 Skin Cancer Diagnostics Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Skin Cancer Diagnostics Industry Market Size (2018-2029)
-
Figure China Skin Cancer Diagnostics Production Volume, Production Value and Growth Rate of Non-melanoma (2018-2029)
-
Figure China Skin Cancer Diagnostics Production Volume, Production Value and Growth Rate of Melanoma (2018-2029)
-
Figure China Skin Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Skin Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Skin Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Skin Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Laboratory (2018-2029)
-
Figure North China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Central China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure South China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure East China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Skin Cancer Diagnostics Market Size and Growth Rate from 2018-2029
-
Figure Skin Cancer Diagnostics Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Skin Cancer Diagnostics Market Share by Type in 2018
-
Figure China Skin Cancer Diagnostics Market Share by Type in 2023
-
Figure China Skin Cancer Diagnostics Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Skin Cancer Diagnostics Production Volume and Growth Rate of Non-melanoma (2018-2023)
-
Figure China Skin Cancer Diagnostics Production Volume and Growth Rate of Melanoma (2018-2023)
-
Figure China Skin Cancer Diagnostics Market Share by Application in 2018
-
Figure China Skin Cancer Diagnostics Market Share by Application in 2023
-
Figure China Skin Cancer Diagnostics Total Market Size and Growth Rate from Consumption End
-
Figure China Skin Cancer Diagnostics Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Skin Cancer Diagnostics Market Size and Growth Rate of Others (2018-2023)
-
Figure China Skin Cancer Diagnostics Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Skin Cancer Diagnostics Market Size and Growth Rate of Laboratory (2018-2023)
-
Table China Skin Cancer Diagnostics Production Volume by Region (2018-2023)
-
Table China Skin Cancer Diagnostics Production Volume Share by Region (2018-2023)
-
Figure China Skin Cancer Diagnostics Production Volume Share by Region (2018-2023)
-
Table China Skin Cancer Diagnostics Production Value by Region (2018-2023)
-
Table China Skin Cancer Diagnostics Production Value Share by Region (2018-2023)
-
Figure China Skin Cancer Diagnostics Production Value Share by Region (2018-2023)
-
Table China Skin Cancer Diagnostics Sales Volume by Region (2018-2023)
-
Table China Skin Cancer Diagnostics Sales Volume Share by Region (2018-2023)
-
Figure China Skin Cancer Diagnostics Sales Volume Share by Region (2018-2023)
-
Table China Skin Cancer Diagnostics Sales Value by Region (2018-2023)
-
Table China Skin Cancer Diagnostics Sales Value Share by Region (2018-2023)
-
Figure China Skin Cancer Diagnostics Sales Value Share by Region (2018-2023)
-
Table North China Skin Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table North China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure North China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table North China Skin Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table North China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure North China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Central China Skin Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table Central China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure Central China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table Central China Skin Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table Central China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure Central China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table South China Skin Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table South China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure South China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table South China Skin Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table South China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure South China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table East China Skin Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table East China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure East China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table East China Skin Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table East China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure East China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Northeast China Skin Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table Northeast China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure Northeast China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table Northeast China Skin Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table Northeast China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Southwest China Skin Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table Southwest China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure Southwest China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table Southwest China Skin Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table Southwest China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Northwest China Skin Cancer Diagnostics Production Volume by Type (2018-2023)
-
Table Northwest China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Figure Northwest China Skin Cancer Diagnostics Production Volume Share by Type (2018-2023)
-
Table Northwest China Skin Cancer Diagnostics Sales Volume by Application (2018-2023)
-
Table Northwest China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Skin Cancer Diagnostics Sales Volume Share by Application (2018-2023)
-
Table Abbott Laboratories Company Profile
-
Table Abbott Laboratories Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table DAMAE Medical Company Profile
-
Table DAMAE Medical Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table F Hoffmann-La Roche Ltd Company Profile
-
Table F Hoffmann-La Roche Ltd Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table DermTech Company Profile
-
Table DermTech Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table NeraCare GmbH Company Profile
-
Table NeraCare GmbH Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Sun Pharmaceutical Industries Ltd Company Profile
-
Table Sun Pharmaceutical Industries Ltd Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Company Profile
-
Table Bristol-Myers Squibb Company Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Daiichi Sankyo Company, Limited Company Profile
-
Table Daiichi Sankyo Company, Limited Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Merck & Co, Inc Company Profile
-
Table Merck & Co, Inc Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Qiagen NV Company Profile
-
Table Qiagen NV Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline PLC Company Profile
-
Table GlaxoSmithKline PLC Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table Castle Biosciences, Inc Company Profile
-
Table Castle Biosciences, Inc Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-
Table AB Science Company Profile
-
Table AB Science Skin Cancer Diagnostics Revenue, Price and Gross (2018-2023)
-